Ocelot Bio
Peptide therapeutic to treat complications of end-stage liver disease
1
Funding Rounds
$36.0m
Money raised
Overview
Peptide therapeutic to treat complications of end-stage liver disease
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Ocelot Bio has raised a total of $36m in funding over 1 rounds.
Key Insights:
- Ocelot Bio Series A round, March 23, 2022: $36m
Ocelot Bio Series A round, March 23, 2022
$36m
Industries
Ocelot Bio is active in the following industries: